10:56 AM EDT, 09/19/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were little changed late Friday morning, declining 0.04% to 1,555.95 on the S&P Europe Select ADR Index, which is up 1% for the week.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 10% and 2.7% respectively. They were followed by internet advertising company Criteo ( CRTO ) and Spanish lender Banco Santander (SAN), which increased 1.7% and 1.3% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and accommodations booking site trivago (TRVG), which fell 3.5% and 1.2% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and pharmaceutical company Ascendis Pharma ( ASND ) , which were down 1.1% and 0.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 8.5% and 3.7% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and pharmaceutical company GSK (GSK), which were up 2.7% and 1% respectively.

The decliners from the UK and Ireland were led by communications company WPP ( WPP ) and biopharmaceutical company NuCana ( NCNA ) , which dropped 4.8% and 3.3% respectively. They were followed by cruise line operator Carnival (CUK) and lender Lloyds Banking Group ( LYG ) , which lost 2.6% and 2.2% respectively.